The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches

Title
The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches
Authors
Keywords
Acetylcholinesterase, Drug-repositioning, Alzheimer’s disease, Molecular docking, Enzyme kinetics
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 109, Issue -, Pages 2513-2526
Publisher
Elsevier BV
Online
2018-12-04
DOI
10.1016/j.biopha.2018.11.115

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now